UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037825 |
|---|---|
| Receipt number | R000043127 |
| Scientific Title | The impact of CONUT in HCC: A Systematic review and Meta-analysis |
| Date of disclosure of the study information | 2019/08/28 |
| Last modified on | 2020/04/25 21:14:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Acronym
The impact of CONUT in HCC: A Systematic review and Meta-analysis
Scientific Title
The impact of CONUT in HCC: A Systematic review and Meta-analysis
Scientific Title:Acronym
The impact of CONUT in HCC: A Systematic review and Meta-analysis
Region
| Europe |
Condition
Condition
Hepatocellular Carcinoma
Classification by specialty
| Surgery in general | Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This systematic review and meta-analysis aimed to investigate the association between the CONUT score and outcomes in patients undergoing hepatectomy for hepatocellular carcinoma.
Basic objectives2
Others
Basic objectives -Others
N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The primary endpoint was long-term survival including overall survival (OS) and recurrence/relapse-free survival (RFS).
Key secondary outcomes
Secondary endpoints were short-term outcomes: postoperative complications, mortality and the clinicopathological parameters.
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Inclusion criteria were as follows: patients undergoing hepatectomy for HCC; the assessment of the CONUT score; and postoperative outcomes.
Key exclusion criteria
Records without abstracts, conference abstracts, case reports, and reviews were excluded.
Target sample size
4500
Research contact person
Name of lead principal investigator
| 1st name | Kosei |
| Middle name | |
| Last name | Takagi |
Organization
Erasmus MC
Division name
Surgery
Zip code
3015 GD
Address
Dr. Molewaterplein 40,
TEL
+31643802627
k.takagi@erasmusmc.nl
Public contact
Name of contact person
| 1st name | Kosei |
| Middle name | |
| Last name | Takagi |
Organization
Erasmus MC
Division name
Surgery
Zip code
3015 GD
Address
Dr. Molewaterplein 40,
TEL
+31643802627
Homepage URL
k.takagi@erasmusmc.nl
Sponsor or person
Institute
Erasmus MC
Institute
Department
Personal name
Funding Source
Organization
N/A
Organization
Division
Category of Funding Organization
Outside Japan
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
+31643802627
k.takagi@erasmusmc.nl
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 08 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 07 | Month | 01 | Day |
Date of IRB
| 2019 | Year | 07 | Month | 01 | Day |
Anticipated trial start date
| 2019 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2019 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Ethical approval: No ethical approval or informed consent statement was required for this review article.
Management information
Registered date
| 2019 | Year | 08 | Month | 28 | Day |
Last modified on
| 2020 | Year | 04 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043127
